Drug news
FDA approves FreeStyle InsuLinx Blood Glucose Monitoring System (Abbott)
The FDA has issued clearance for the FreeStyle InsuLinx Blood Glucose Monitoring System, from Abbott. This machine is designed to translate blood glucose measurements and individual patient data into accurately calculated insulin dosing suggestions. It includes a touch-screen interface, automated logbook and several personalization features designed to improve the diabetes management experience for patients. This device is equipped with built-in FreeStyle Auto-Assist software that enables patients to track progress, analyze trends and easily display data for their health care providers. It is compatible with the FreeStyle InsuLinx blood glucose test strips.